« Return to News | Technology Solutions

Certara acquires Great Lakes Drug Development

Thursday, August 15, 2013 10:11 AM

Certara, a provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, has acquired drug development consultancy Great Lakes Drug Development (GLDD), based in Brighton, Mich. Both companies focus on pharmacokinetic (PK) and pharmacodynamic (PD) analysis, project management and pharmacometric modeling and simulation. GLDD focuses on early development work, while Certara’s products and services span the entire drug development continuum.

“This acquisition will enable us to leverage the significant synergies between Certara’s and GLDD’s business focus, experience and culture, while expanding our customer base,” said Daniel Weiner, Ph.D., senior vice president and general manager at Certara. 

The GLDD office in Michigan will become the sixth in Certara’s worldwide consultancy operations, located in Sunnyvale, Calif.; Cary, N.C.; Montreal; Tokyo; and England.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.